Over the past few decades, the Food Sector has faced continued increases in regulatory requirements for compliance. Regulatory risk is, however, only one of the considerations this sector must evaluate...
Nexis Diligence™ can help you mitigate business risk by making it easier to vet and monitor clients, agents, partners, suppliers, investments, and other third parties in a quick and comprehensive...
A due diligence checklist takes you step-by-step through the information you need to consider to help carry out a thorough investigation when you’re contemplating a new commercial relationship, a...
Organizations must navigate a complicated web of sanctions—and it’s not just banks and financial institutions that are subject to the sanctions. Increasingly, companies across various industries...
Why beneficial ownership matters At the most fundamental level, financial services firms, and indeed all companies operating internationally, need to have confidence that the third parties that they deal...
Due Diligence
Patient safety, clinical trial management, mergers and acquisitions, research and development, sales and marketing, and pricing structures are all areas where failure to mitigate risk effectively can lead to reputational damage, financial loss and regulatory enforcement action. In just a couple of decades, the pharmaceuticals and life sciences industry has changed beyond recognition in response to globalization and demand for new products. What does the current risk landscape look like for pharmaceuticals and life sciences sector?